Aggiornamento in Medicina by Xagena

–

Articoli

• Scompenso cardiaco ALERT
• Ematologia ALERT
• Ginecologia ALERT
• Medicina Update by Xagena
• Oncologia Newsletter by Xagena
• Dermatologia Newsletter by Xagena
• Aggiornamenti in Cardiologia by Xagena
• Reumatologia Newsletter by Xagena
• Malattie ematologiche Newsletter by Xagena
• Ematologia Newsletter by Xagena
• Infettivologia Newsletter by Xagena
• Farmaci Newsletter by Xagena
• Vaccini COVID Newsletter by Xagena
• Malattie infettive Newsletter by Xagena
• Pediatria Newsletter by Xagena
• Oncologia Newsletter by Xagena
• Farmaci Newsletter by Xagena
• Vaccini Newsletter by Xagena
• Reumatologia ALERT by Xagena
• Oncologia ALERT by Xagena
• Farmacia ALERT by Xagena
• COVID, la situazione sta peggiorando rispetto a luglio 2020 nonostante l’imponente campagna vaccinale
• Vaccinazione con vaccino AstraZeneca & Rischio di Sindrome di Guillain-Barré
• Vaccini COVID a vettore virale & Rischio di sindrome di Guillain-Barré
• Novità nel trattamento dell’Alzheimer: Donanemab
• Oncologia Newsletter by Xagena
• Ematologia Newsletter by Xagena
• Neurologia Newsletter by Xagena
• Farmaci Newsletter by Xagena
• Cardiologia Newsletter by Xagena
• Farmacia Newsletter by Xagena
• Dermatologia Newsletter
• Reumatologia Newsletter
• Ematologia Newsletter
• Tumori Newsletter
• Neurologia Newsletter
• Vaccini Newsletter
• Oncologia Newsletter
• Cardiologia Newsletter
• Ematologia Newsletter
• Oncologia Newsletter by Xagena
• Dermatologia Newsletter by Xagena
• Vaccini Newsletter by Xagena
• Ematologia Newsletter by Xagena
• Infettivologia Newsletter by Xagena
• Oncologia Update by Xagena
• Aritmologia Newsletter by Xagena
• Malattie rare Newsletter by Xagena
• Cardiologia Newsletter by Xagena
• Ematologia Newsletter by Xagena
• Reumatologia Newsletter by Xagena
• Nefrologia – Urologia Newsletter by Xagena
• Farmacia Newsletter by Xagena
• Cardiologia Newsletter by Xagena
• Vaccini Newsletter by Xagena
• Tumori – ASCO Meeting by Xagena
• Farmaci Newsletter by Xagena
• Ematologia Newsletter by Xagena
• Reumatologia Newsletter by Xagena
• Ematologia Newsletter by Xagena
• Oncologia Newsletter by Xagena
• Gran Bretagna: le persone con storia di reazioni allergiche a alimenti farmaci e vaccini non devono vaccinarsi
• Tagrisso come terapia adiuvante nel cancro al polmone non-a-piccole cellule EGFR-mutato: FDA
• ALERT Vaccini by Xagena
• ALERT Infettivologia by Xagena
• Infettivologia Newsletter by Xagena
• ALERT Vaccini !
• COVID: Reazioni avverse del vaccino a RNA messaggero di Pfizer / BioNTech
• Infettivologia Newsletter by Xagena
• Reumatologia Newsletter by Xagena
• Cardiologia Newsletter by Xagena
• Neurologia Newsletter by Xagena
• Dermatologia Newsletter by Xagena
• Farmaci Newsletter by Xagena
• Ematologia Newsletter by Xagena
• Cardiologia Newsletter by Xagena
• Tumore al Polmone: Dati a 5 anni di Keytruda – REPORT by Xagena
• Nefrologia & urologia Newsletter by Xagena
• Aggiornamento in Ginecologia by Xagena
• Malattie rare: Sindrome da chilomicronemia familiare
• Neurologia Newsletter by Xagena
• Benessere ALERT by Xagena
• Scompenso Cardiaco Newsletter by Xagena
• Virologia News by Xagena
• Malattie rare by Xagena
• Riservato agli Oncologi: Thoracic Cancer News
• Diabete Newsletter by Xagena
• Ginecologia Newsletter by Xagena
• Tumori Newsletter by Xagena
• Urologia & Nefrologia Newsletter by Xagena
• Farmaci Newsletter by Xagena
• Ematologia Newsletter by Xagena
• Infettivologia Newsletter by Xagena
• Cardiologia Newsletter by Xagena
• Novità in Terapia: Farmaci News by Xagena
• Aritmologia Newsletter by Xagena
• Newsletter Endocrinologia & Metabolismo by Xagena
• Newsletter Neurologia by Xagena
• Medical News by Xagena – Update in Medicine

Iscrizione gratuita alle Newsletter Medicina by Xagena